September 17, 2019

Explanation of Clinical Trials for Kentucky Mesothelioma Patients

Unfortunately, the current prognosis for treatment of mesothelioma is poor. Thankfully, there is a great deal of new and ongoing research into improving the prognosis for mesothelioma sufferers. Many universities, cancer centers and companies are performing trials on a variety of new drugs and treatment options for mesothelioma. As a Kentucky mesothelioma patient it is important that you understand the clinical trial process if you are interested in trying experimental treatments.

There are a few phases of clinical trials. They include:

  • Phase I – This is a very small trial (20-80 patients) to first test the safety and effectiveness of a treatment on humans.
  • Phase II – After phase I, a larger trial (100-300 patients) is performed to further test safety and effectiveness.
  • Phase III – At this point, a much larger trial (1000-3000 patients) is performed to confirm the treatment’s effectiveness, monitor side effects and compare it to commonly used treatments.
  • Phase IV – After a treatment is released, further studies may be performed to monitor its usage.

If you are interested in becoming involved in any study related to mesothelioma treatment in Kentucky or throughout the US, you should visit the government’s website listing active trials for pleural mesothelioma treatment. It is important to remember that experimental treatments may carry an increased risk of short or long-term side effects. Be sure to discuss any potential clinical trials you might partake in with your medical professional.

Mesothelioma is a rare form of cancer generally caused by prolonged or high exposure to asbestos. You may have an increased risk of developing mesothelioma if you worked in certain industries between the 1920s and 1980s. Our Kentucky mesothelioma lawyers have experience handling complex mesothelioma cases. Contact us for your free Kentucky mesothelioma case evaluation.